ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Total current assets

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndTotal current assets (Million USD)YoY (%)
Dec 31, 202525,996+9.89%
Dec 31, 202423,656+4.35%
Dec 31, 202322,670-10.13%
Dec 31, 202225,224+4.06%
Dec 31, 202124,239+18.58%
Dec 31, 202020,441+30.47%
Dec 31, 201915,667+7.07%
Dec 31, 201814,632-27.37%
Dec 31, 201720,147-24.76%
Dec 31, 201626,776+89.16%
Dec 31, 201514,155-26.46%
Dec 31, 201319,247-19.02%
Dec 31, 201123,769+6.50%
Dec 31, 201022,318

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat